03 August 2018
Visiongain has launched a new pharma report Contraceptive Devices Market Report : Male Condoms, Female Condoms, Diaphragms, Sponges, Vaginal Rings, Subdermal/Contraceptive Implants, Intra-uterine Devices (IUDs), Copper IUD, Hormonal IUD
The evolution of contraceptive devices has opened a new outlook in the healthcare industry. Growth rate exhibited by the contraceptive devices market despite the shortages and lack of awareness among the population in various countries, confirms the positive growth prospects going ahead. The contraceptive devices market is highly competitive and has reached maturity resulting in single digit growth rates of prominent devices such as condoms, diaphragms, vaginal rings, sponges, etc.
The lead analyst of the report commented “The global contraceptive devices market is expected to experience a significant growth over the forecast period. The main drivers for the growth include rapid growth in population, development of technologically advanced contraceptive devices, huge burden of sexually transmitted diseases and HIV, increasing adoption of contraceptive devices and supportive government authorities.
The rising prevalence of sexually transmitted diseases (STDs) is increasing the need of more innovative products in the contraceptive devices market. At present, condoms are the only contraceptive devices that prevent from the risk of sexually transmitted infections & HIV therefore; manufacturers across the globe are enormously investing in R&D to come up with a product that would be reminiscent of contraceptive condoms in the prevention of sexually transmitted infections & HIV along with unintended pregnancies and birth control.”
Leading companies featured in the report include Bayer AG, Reckitt Benckiser Group plc
Merck Sharp & Dohme Corp., Church & Dwight Co., Inc., Teva Pharmaceutical Industries, Ltd.
Allergan plc, Ansell Limited (Now Humanwell), The Female Health Company (a division of VERU Inc.), Karex Industries, Mayer Laboratories, Kessel Medintim GmbH, Okamato Industries, Inc., Agile Therapeutics, Inc., Eurogine S.L.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
As lockdowns were imposed in all the countries, diagnosis rates went down in majority of countries during the year hitting the drug sales for some period. Although lockdown measures have been eased up in most countries by mid-year 2020, this trend is expected to continue beyond 2020, stock up of medicines by patients is likely to propel the drug sales in majority of the developed economies, which account for majority of rare diseases.
02 March 2021
Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.
26 February 2021
The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.
22 February 2021
The global Big Data Analytics in Healthcare market has been growing considerably owing to the rising technological advancement, growing investment, and cohesive government policies.